Heterocyclic compounds having angiotensin II antagonistic activi

Details Heterocyclic compounds having angiotensin II antagonistic activi Heterocyclic compounds having angiotensin II antagonistic activi

1993-12-22

1996-03-05

Gerstl, Robert

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514364, 548136, 548144, C07D41310, A61K 3141

Patent

active

054968356

ABSTRACT:
This invention relates to a compound represented by the formula ##STR1## wherein the ring A stands for a 5-10 membered aromatic heterocyclic group optionally having, besides R.sup.1 and R.sup.2, further substituents; R.sup.1 stands for an optionally substituted hydrocarbon residue which is optionally bonded through a hetero-atom; R.sup.2 stands for a group capable of liberating proton in a living body or a group convertible thereinto; R.sup.3 stands for an 5-7 membered optionally substituted heterocyclic residue having, as a group capable of constituting the ring, carbonyl group, thiocarbonyl group, an optionally oxidized sulfur atom or a group convertible into them; X shows that the ring Y and the ring W are bonded to each other directly or through a spacer having an atomic length of two or less; the ring W and the ring Y are each an optionally substituted aromatic hydrocarbon or aromatic heterocyclic residue; and n denotes an integer of 1 to 3, or a salt thereof and to an angiotensin II antagonistic agent containing the compound (I) or a salt thereof.

REFERENCES:
patent: 5243054 (1993-09-01), Naka

Affiliated with

Also associated with

Rating

Heterocyclic compounds having angiotensin II antagonistic activi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclic compounds having angiotensin II antagonistic activi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compounds having angiotensin II antagonistic activi will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1413153